Logo image of HSAI

HESAI GROUP (HSAI) Stock Fundamental Analysis

NASDAQ:HSAI - Nasdaq - US4280501085 - ADR - Currency: USD

21.3  0 (0%)

After market: 21.25 -0.05 (-0.23%)

Fundamental Rating

4

Overall HSAI gets a fundamental rating of 4 out of 10. We evaluated HSAI against 80 industry peers in the Automobile Components industry. While HSAI seems to be doing ok healthwise, there are quite some concerns on its profitability. HSAI is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year HSAI was profitable.
In the past 5 years HSAI always reported negative net income.
In multiple years HSAI reported negative operating cash flow during the last 5 years.
HSAI Yearly Net Income VS EBIT VS OCF VS FCFHSAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of -0.23%, HSAI is doing worse than 73.75% of the companies in the same industry.
HSAI's Return On Equity of -0.31% is on the low side compared to the rest of the industry. HSAI is outperformed by 72.50% of its industry peers.
Industry RankSector Rank
ROA -0.23%
ROE -0.31%
ROIC N/A
ROA(3y)-9.86%
ROA(5y)-19.98%
ROE(3y)-13.74%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
HSAI Yearly ROA, ROE, ROICHSAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

HSAI has a better Gross Margin (42.99%) than 97.50% of its industry peers.
In the last couple of years the Gross Margin of HSAI has declined.
HSAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-9.55%
HSAI Yearly Profit, Operating, Gross MarginsHSAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

6

2. Health

2.1 Basic Checks

HSAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
HSAI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HSAI has more shares outstanding
Compared to 1 year ago, HSAI has a worse debt to assets ratio.
HSAI Yearly Shares OutstandingHSAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HSAI Yearly Total Debt VS Total AssetsHSAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

HSAI has an Altman-Z score of 8.03. This indicates that HSAI is financially healthy and has little risk of bankruptcy at the moment.
HSAI has a better Altman-Z score (8.03) than 91.25% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that HSAI is not too dependend on debt financing.
HSAI has a Debt to Equity ratio of 0.08. This is amongst the best in the industry. HSAI outperforms 88.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 8.03
ROIC/WACCN/A
WACC7.83%
HSAI Yearly LT Debt VS Equity VS FCFHSAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

HSAI has a Current Ratio of 4.06. This indicates that HSAI is financially healthy and has no problem in meeting its short term obligations.
HSAI has a Current ratio of 4.06. This is amongst the best in the industry. HSAI outperforms 91.25% of its industry peers.
HSAI has a Quick Ratio of 3.62. This indicates that HSAI is financially healthy and has no problem in meeting its short term obligations.
HSAI's Quick ratio of 3.62 is amongst the best of the industry. HSAI outperforms 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.62
HSAI Yearly Current Assets VS Current LiabilitesHSAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. Growth

3.1 Past

HSAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.02%, which is quite impressive.
HSAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.20%.
The Revenue has been growing by 42.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)126.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)24.2%
Revenue growth 3Y42.3%
Revenue growth 5Y42.94%
Sales Q2Q%46.27%

3.2 Future

Based on estimates for the next years, HSAI will show a very strong growth in Earnings Per Share. The EPS will grow by 215.76% on average per year.
HSAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.14% yearly.
EPS Next Y5162.61%
EPS Next 2Y965.58%
EPS Next 3Y464.61%
EPS Next 5Y215.76%
Revenue Next Year56.52%
Revenue Next 2Y49.98%
Revenue Next 3Y42.63%
Revenue Next 5Y40.14%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HSAI Yearly Revenue VS EstimatesHSAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
HSAI Yearly EPS VS EstimatesHSAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5 10

2

4. Valuation

4.1 Price/Earnings Ratio

HSAI is valuated quite expensively with a Price/Earnings ratio of 236.67.
HSAI's Price/Earnings ratio is rather expensive when compared to the industry. HSAI is more expensive than 81.25% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.04, HSAI is valued quite expensively.
The Price/Forward Earnings ratio is 33.57, which means the current valuation is very expensive for HSAI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HSAI indicates a slightly more expensive valuation: HSAI is more expensive than 77.50% of the companies listed in the same industry.
HSAI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 37.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 236.67
Fwd PE 33.57
HSAI Price Earnings VS Forward Price EarningsHSAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HSAI indicates a rather expensive valuation: HSAI more expensive than 85.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 629.58
HSAI Per share dataHSAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

HSAI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HSAI's earnings are expected to grow with 464.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y965.58%
EPS Next 3Y464.61%

0

5. Dividend

5.1 Amount

No dividends for HSAI!.
Industry RankSector Rank
Dividend Yield N/A

HESAI GROUP

NASDAQ:HSAI (7/25/2025, 8:00:01 PM)

After market: 21.25 -0.05 (-0.23%)

21.3

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-26 2025-05-26/amc
Earnings (Next)08-18 2025-08-18
Inst Owners54.92%
Inst Owner Change-0.12%
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap2.82B
Analysts86.36
Price Target25.56 (20%)
Short Float %5.72%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)66.12%
Min EPS beat(2)-13.01%
Max EPS beat(2)145.25%
EPS beat(4)2
Avg EPS beat(4)10.14%
Min EPS beat(4)-108.33%
Max EPS beat(4)145.25%
EPS beat(8)6
Avg EPS beat(8)21.71%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.85%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)-2.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-4.88%
Max Revenue beat(4)8.02%
Revenue beat(8)4
Avg Revenue beat(8)2.26%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.86%
PT rev (3m)6.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-23.74%
EPS NY rev (3m)-14.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-3.75%
Valuation
Industry RankSector Rank
PE 236.67
Fwd PE 33.57
P/S 9
P/FCF N/A
P/OCF N/A
P/B 4.72
P/tB 4.81
EV/EBITDA 629.58
EPS(TTM)0.09
EY0.42%
EPS(NY)0.63
Fwd EY2.98%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.37
BVpS4.51
TBVpS4.43
PEG (NY)0.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -0.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.99%
FCFM N/A
ROA(3y)-9.86%
ROA(5y)-19.98%
ROE(3y)-13.74%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-9.55%
F-ScoreN/A
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 10.73
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 3.62
Altman-Z 8.03
F-ScoreN/A
WACC7.83%
ROIC/WACCN/A
Cap/Depr(3y)378.06%
Cap/Depr(5y)506.05%
Cap/Sales(3y)18.38%
Cap/Sales(5y)22.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y5162.61%
EPS Next 2Y965.58%
EPS Next 3Y464.61%
EPS Next 5Y215.76%
Revenue 1Y (TTM)24.2%
Revenue growth 3Y42.3%
Revenue growth 5Y42.94%
Sales Q2Q%46.27%
Revenue Next Year56.52%
Revenue Next 2Y49.98%
Revenue Next 3Y42.63%
Revenue Next 5Y40.14%
EBIT growth 1Y82.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year262.82%
EBIT Next 3Y89.56%
EBIT Next 5Y71.4%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.77%
OCF growth 3YN/A
OCF growth 5Y6.75%